Clinical Trials · NCT00079924

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

CompletedPhase 4Teriparatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
200
Start date
Nov 2004
Locations
10 sites, United States
Primary endpoint
Change in calcium values after beginning teriparatide
View Teriparatide compound reference